Expanded access to tazbentetol for people with ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This program lets people with ALS try an experimental medicine called tazbentetol when they cannot join other ALS studies. The goal is to make this treatment available to more people with ALS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of ALS (amyotrophic lateral sclerosis).
- You are between 18 and 85 years old.
- You are not eligible for other ALS clinical trials.
- Your breathing capacity is at least 35% of the expected value for your age and height.
- If you take standard ALS medications, your dose is stable for at least 30 days before starting the study drug.
- You can swallow pills whole every day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tofersen, a drug that targets a protein linked to ALS, can help people who have ALS but do not have mutations in the SOD1 or FUS genes. It aims to slow disease progression in those diagnosed within the last 2 years.
This trial tests a new drug, CTx1000, for people with ALS. It aims to see if the drug is safe and tolerable, and may offer a new treatment option.
This study tests a non-invasive brain stimulation technique (called transcutaneous spinal direct current stimulation and transcranial magnetic stimulation) to see if it can calm overactive nerves in people with ALS. You may be a good fit if you have ALS that started less than 3 years ago and your breathing is still strong.
This trial tests a new medicine, CB03-154, to see if it can help people with ALS. Researchers are comparing different doses to find the safest and most effective one.
This trial tests two new medicines (galunisertib and nerandomilast) together in people with a specific type of ALS. The combination may slow down the damage in the nervous system, and the trial is looking at whether it's safe and helps.
This study tests an investigational drug called tazbentetol for people with ALS (amyotrophic lateral sclerosis), a disease that affects nerve cells controlling muscles. The goal is to see if it is safe and effective, and it may help slow the progression of the disease.
Hear when a new ALS (Amyotrophic Lateral Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.